临床特征 | P值 | HR (95% CI) |
性别(男比女) | 0.016 | 1.370 (1.060~1.770) |
年龄(≥60岁比<60岁) | 0.003 | 1.493 (1.145~1.948) |
TNM分期(IIIB期~IVB期比I期~IIIA期) | <0.001 | 3.559 (2.620~4.835) |
病理分型(腺癌比鳞癌) | 0.006 | 0.667 (0.501~0.889) |
手术治疗(有比无) | <0.001 | 0.454 (0.341~0.603) |
吸烟史(有比无) | 0.015 | 1.356 (1.061~1.732) |
癌胚抗原 | 0.030 | 1.001 (1.000~1.002) |
可溶性细胞角蛋白19片段 | <0.001 | 1.016 (1.009~1.024) |
NSE | <0.001 | 1.037 (1.025~1.049) |
PAB | <0.001 | 0.993 (0.991~0.995) |
D-二聚体 | 0.553 | 1.011 (0.977~1.045) |
SII | <0.001 | 1.000 (1.000~1.001) |
SII/ALB | <0.001 | 1.015 (1.011~1.018) |
CAR | <0.001 | 1.411 (1.262~1.579) |
PLR | <0.001 | 1.003 (1.002~1.004) |